{"DataElement":{"publicId":"7307861","version":"1","preferredName":"Disease Status NCCN ALL Response Criterion CNS Disease Type","preferredDefinition":"A description of the NCCN ALL disease response criteria for CNS disease.","longName":"DIS_NCCN_ALL_RSP_CRT_CNS_TY","context":"DCI","contextVersion":"1","DataElementConcept":{"publicId":"2512861","version":"1","preferredName":"Disease or Disorder Status","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A condition or state at a particular time.","longName":"2404658v1.0:2320064v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2320064","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC71B93E-037B-5AD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B898979-184A-3A90-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7307858","version":"1","preferredName":"NCCN ALL Response Criterion CNS Disease Type","preferredDefinition":"An alliance of 19 leading US cancer centers, an authoritative source of information to help patients and health professionals make informed decisions about cancer care. Through the collective expertise of its member institutions, the NCCN develops, updates, and disseminates a complete library of clinical practice guidelines. These guidelines are the standard for clinical policy in oncology._Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia._The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison._A non-neoplastic or neoplastic disorder which affects the brain and/or spinal cord._Something distinguishable as an identifiable class based on common qualities.","longName":"NCCN_ALL_RSP_CRT_CNS_DIS_TY","context":"DCI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not Assessed","valueDescription":"NOT ASSESSED","ValueMeaning":{"publicId":"2559594","version":"1","preferredName":"NOT ASSESSED","longName":"2559594","preferredDefinition":"Indicates that an assessment was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Assessed","conceptCode":"C139527","definition":"Indicates that an assessment was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5D7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A3FEC5-850B-3168-E053-4EBD850A84FE","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"CNS Relapse","valueDescription":"NCCN ALL Response Criteria for CNS Disease CNS Relapse","ValueMeaning":{"publicId":"7307859","version":"1","preferredName":"NCCN ALL Response Criteria for CNS Disease CNS Relapse","longName":"7307859","preferredDefinition":"New development of CNS-3 status or clinical signs of CNS leukemia such as facial nerve palsy, brain/eye involvement, or hypothalamic syndrome without another explanation. (Adapted from NCCN Guidelines, Version 1.2020, February 20, 2020)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NCCN ALL Response Criteria for CNS Disease CNS Relapse","conceptCode":"C172175","definition":"New development of CNS-3 status or clinical signs of CNS leukemia such as facial nerve palsy, brain/eye involvement, or hypothalamic syndrome without another explanation. (Adapted from NCCN Guidelines, Version 1.2020, February 20, 2020)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6A3FEC5-8517-3168-E053-4EBD850A84FE","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A3FEC5-8530-3168-E053-4EBD850A84FE","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"CNS Remission","valueDescription":"NCCN ALL Response Criteria for CNS Disease CNS Remission","ValueMeaning":{"publicId":"7307860","version":"1","preferredName":"NCCN ALL Response Criteria for CNS Disease CNS Remission","longName":"7307860","preferredDefinition":"Achievement of CNS-1 status in a patient with CNS-2 or CNS-3 status at study entry. (Adapted from NCCN Guidelines, Version 1.2020, February 20, 2020)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NCCN ALL Response Criteria for CNS Disease CNS Remission","conceptCode":"C172174","definition":"Achievement of CNS-1 status in a patient with CNS-2 or CNS-3 status at study entry. (Adapted from NCCN Guidelines, Version 1.2020, February 20, 2020)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6A3FEC5-853C-3168-E053-4EBD850A84FE","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A3FEC5-8555-3168-E053-4EBD850A84FE","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7307857","version":"1","preferredName":"National Comprehensive Cancer Network Acute Lymphoblastic Leukemia Disease Response Criterion Central Nervous System Disorder Type","preferredDefinition":"An alliance of 19 leading US cancer centers, an authoritative source of information to help patients and health professionals make informed decisions about cancer care. Through the collective expertise of its member institutions, the NCCN develops, updates, and disseminates a complete library of clinical practice guidelines. These guidelines are the standard for clinical policy in oncology.:Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.:The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.:That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.:A non-neoplastic or neoplastic disorder which affects the brain and/or spinal cord.:Something distinguishable as an identifiable class based on common qualities.","longName":"7307857v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Comprehensive Cancer Network","conceptCode":"C39471","definition":"An alliance of 19 leading US cancer centers, an authoritative source of information to help patients and health professionals make informed decisions about cancer care. Through the collective expertise of its member institutions, the NCCN develops, updates, and disseminates a complete library of clinical practice guidelines. These guidelines are the standard for clinical policy in oncology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Acute Lymphoblastic Leukemia","conceptCode":"C3167","definition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Criterion","conceptCode":"C25466","definition":"That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Central Nervous System Disorder","conceptCode":"C2934","definition":"A non-neoplastic or neoplastic disorder which affects the brain and/or spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6A3FEC5-84E5-3168-E053-4EBD850A84FE","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6A3FEC5-84F6-3168-E053-4EBD850A84FE","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"KUMMEROA","dateModified":"2020-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Acute Lymphoblastic Leukemia","type":"Preferred Question Text","description":"Acute Lymphoblastic Leukemia Response Criteria for CNS Disease","url":null,"context":"DCI"}],"origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6A40FCA-3181-0ECE-E053-4EBD850A4043","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"KUMMEROA","dateModified":"2020-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}